Dr. Brad Steven Kahl, MD
- Medicare services, 2024
- 3,395
- Medicare patients, 2024
- 456
- Part D claims, 2024
- 904
- Publications
- 250
- Clinical trials
- 18
- Practice address
- One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110
- Practice phone
- Call (314) 747-3000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Kahl's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Brad Steven Kahl is a medical oncologist in Saint Louis, Missouri
Dr. Kahl practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.
Dr. Kahl's NPI, 1407822430, was assigned on February 28, 2006. Dr. Kahl graduated from Tufts University School Of Medicine in 1994. Dr. Kahl holds Missouri license 2015029481.
- NPI
- 1407822430NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3779613757
- NPI enumeration date
- February 28, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (314) 747-3000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 58
- Medical school graduation
- 1994
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Brad Steven Kahl practices at 2 locations in Saint Louis, Missouri
Dr. Kahl's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Kahl also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.
- Barnes-Jewish HospitalPrimaryOne Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 · St. Louis CityPhone(314) 747-3000
- Barnes-Jewish Hospital1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 · Saint Louis CityPhone(314) 747-3000
Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; and Dmand AI Practice Data
Dr. Brad Steven Kahl is affiliated with 6 sites of care and 1 medical group
Dr. Kahl's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Kahl is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Kahl to 3 more hospitals and 1 group practice or clinic, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Brad Steven Kahl's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kahl practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Barnes-Jewish Hospital | Available with a free account |
| +5 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across BJC Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Brad Steven Kahl is one of 120 medical oncologists in Missouri
Medical oncology is Dr. Kahl's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Kahl is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Kahl's licenses on file in 3 states: Missouri, Illinois and Wisconsin.
Specialties and state licenses
- Medical oncology, MissouriPrimary
- Illinois license
- Wisconsin license
Clinical focus
Dmand AI lists chronic leukemia, immune deficiency disease, lung cancer, lymphoma, multiple myeloma, neutropenia and prostate cancer among the conditions Dr. Kahl treats.
Medical oncologists near Dr. Kahl
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Brad Steven Kahl billed Medicare for 3,395 services in 2024
CMS data shows 3,395 Medicare services from Dr. Kahl across 23 procedure codes in 2024, for 456 Medicare patients. Medicare paid $124,765 for them.
Dr. Kahl's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 15,5332024: 1,94387%
- Office and hospital visits
- 2023: 8272024: 8847%
- Tests and treatments
- 2023: 7972024: 42846%
- Surgery
- 2023: 3142024: 14055%
- Other services
- 2023: 212024: 0100%
Where Dr. Kahl's Medicare services took place, 2024
- In an office2,98888%
- In a facility40712%
Dr. Kahl compared with the Missouri median for medical oncologists, 2024
- Dr. Kahl
- Missouri median
- Medicare services
- 3,395vs 1,2462.7 times
- Medicare patients
- 456vs 2242.0 times
- Part D claims
- 697vs 56024% above
Medians across 125 medical oncologists in Missouri with Dmand AI profiles that report each measure.
Dr. Kahl's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Kahl?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kahl and other medical oncologists in Missouri.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Brad Steven Kahl treated 456 Medicare patients in 2024, average age 73
CMS counts 456 Medicare patients who saw Dr. Kahl in 2024. The largest group is 65 to 74, with 219 patients. 73% of them have high blood pressure, and 70% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Kahl's median patient age at 73, with 42% women.
Dr. Kahl's Medicare patients by age, 2024
Dr. Kahl's Medicare patients by sex, 2024
- Women18541%
- Men27159%
Chronic conditions among Dr. Kahl's Medicare patients, 2024
- High blood pressure73%
- High cholesterol70%
- Arthritis46%
- Chronic kidney disease29%
- Ischemic heart disease29%
- Anxiety28%
- Cancer28%
- Diabetes26%
Share of Medicare patients with each condition. A patient can have several.
Dr. Kahl's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women42%
- Men58%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Brad Steven Kahl wrote 904 Medicare Part D claims in 2024
In 2024, Dr. Kahl wrote 904 Medicare Part D claims for 174 patients. 60% of them were for generic drugs. CMS names the drug for 697 of them, across 19 drugs with 11 or more claims each, at $3,541,355 in total drug cost. In 2023, CMS named 597 claims across 17 drugs.
Dr. Kahl's Part D claims by kind of drug, 2024
- Generic545 claims60%
- Brand-name359 claims40%
Dr. Kahl's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Kahl's Part D claims, 2024
- Opioids2%15 of 904 claims
- Antibiotics4%35 of 904 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 5972024: 69717%
Drugs named by CMS: 19 in 2024, 17 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Brad Steven Kahl scored 84 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Kahl for performance year 2024, reported as part of a group. Dr. Kahl accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Kahl's MIPS scores, performance year 2024
- 84of 100Final score
- 71.6of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 76of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Brad Steven Kahl has 250 publications on record
Dmand AI links 250 papers to Dr. Kahl, published from 2006 to 2025. 2016 was the busiest year, with 19. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Rituximab and Lymphoma, Mantle-Cell. Dr. Kahl has published most often in Leuk Lymphoma. Dr. Kahl's most frequent co-authors are Nancy Lee Bartlett, MD, John P. Leonard, MD and Ranjana Advani, MD.
Dr. Kahl's papers by year, 2016 to 2025
Topics Dr. Kahl writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Rituximab
- Lymphoma, Mantle-Cell
- Vincristine
- Cyclophosphamide
- Doxorubicin
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
Dr. Kahl's most frequent co-authors
- Nancy Lee Bartlett, MD35 shared papers
- John P. Leonard, MD35 shared papers
- Ranjana Advani, MD23 shared papers
Recent publications by Dr. Kahl
See who Dr. Kahl researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kahl works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Brad Steven Kahl has worked on 18 clinical trials
Dmand AI links Dr. Kahl to 18 clinical trials, 11 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell and Lymphoma, Follicular. University of Wisconsin, Madison sponsors the most, 5.
Clinical trials with Dr. Kahl by phase
- 3Phase 1: 3 trials
- 11Phase 2: 11 trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Kahl's trials
- Lymphoma, Non-Hodgkin
- Lymphoma, Mantle-Cell
- Lymphoma, Follicular
- Lymphoma
- Lymphoma, B-Cell, Marginal Zone
Investigators on the most trials with Dr. Kahl
- Andrew M. Evens, DO, MS2 shared trials
- Timothy S. Fenske, MD2 shared trials
- Edward J. Gorak, DO2 shared trials
Recent clinical trials with Dr. Kahl
HMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHL (opens in a new tab)
Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma (opens in a new tab)
Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma (opens in a new tab)
Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL) (opens in a new tab)
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Brad Steven Kahl received $420,019 in industry payments from 2016 to 2025
CMS Open Payments shows 349 general payments to Dr. Kahl from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 83% of the total. Genentech, Inc. paid the most, $99,132. It also lists 19 research payments totaling $14,147 from 2016 to 2024.
General payments to Dr. Kahl by program year, 2016 to 2025
General payments to Dr. Kahl by kind, 2016 to 2025
- Consulting fees$346,53783%
- Travel and lodging$39,1309%
- Speaker and faculty fees$13,4393%
- Honoraria$13,1703%
- Other$7,7432%
Companies that paid Dr. Kahl the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Brad Steven Kahl has 2 awards and honors on record
Dmand AI lists 2 awards for Dr. Kahl, most recently Regional Top Doctor in 2014.
Awards and honors for Dr. Kahl
- 2014
- Regional Top Doctor
- 2011
- CMS Stage 1 EHR
Source: Dmand AI Professional Profile Data
Dr. Brad Steven Kahl graduated from Tufts University School Of Medicine
Dr. Kahl graduated from Tufts University School Of Medicine in 1994. Dr. Kahl is a member of ASCO.
- Medical school
- Board certified in hematology
Source: Dmand AI Professional Profile Data
Dr. Brad Steven Kahl accepts plans from 13 insurance carriers
Dr. Kahl is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.
- Aetna
- Elevance
- Blue Cross Blue Shield of Michigan
- Cigna
- Blue Cross Blue Shield of Massachusetts
- HCSC
- Humana
- Regence Health Plans
- +5 more carriersWith a free account
Plan types Dr. Kahl accepts, by number of carriers
- PPO10
- Medicare9
- HMO4
- POS3
- EPO2
- Medicaid2
Source: Dmand AI Insurance Network Data
Sources for Dr. Brad Steven Kahl's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDmand AI Practice Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Brad Steven Kahl
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Brad Steven Kahl's NPI number?
Dr. Brad Steven Kahl's NPI number is 1407822430. It was assigned on February 28, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Brad Steven Kahl?
Dr. Brad Steven Kahl is a medical oncologist in Saint Louis, Missouri. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Brad Steven Kahl practice?
Dr. Kahl practices at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110. Dr. Kahl also practices at 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110. Dr. Kahl's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dmand AI also links Dr. Kahl to 3 hospitals and 1 group practice or clinic.
What is Dr. Brad Steven Kahl's office phone number?
The practice phone on file for Dr. Kahl is (314) 747-3000.
What is Dr. Brad Steven Kahl's medical license number?
Dr. Kahl holds Missouri license 2015029481, one of the licenses on file in 3 states.
Which states has Dr. Brad Steven Kahl been licensed in?
Dmand AI has state licenses on file for Dr. Kahl in Missouri (2015 to 2026), Illinois (2020 to 2023) and Wisconsin (1995 to 2015).
Which hospitals is Dr. Brad Steven Kahl affiliated with?
Dr. Kahl practices at Barnes-Jewish Hospital in Saint Louis, Missouri. Dr. Kahl is also affiliated with Missouri Baptist Medical Center. Dmand AI links Dr. Kahl to 3 more hospitals.
What medical group is Dr. Brad Steven Kahl part of?
Dr. Kahl is linked to WashU Medicine Psychiatry.
Does Dr. Brad Steven Kahl accept Medicare?
Yes. CMS data shows Dr. Kahl billed Medicare for 3,395 services in 2024, and Dr. Kahl accepts Medicare assignment.
What is Dr. Brad Steven Kahl's MIPS score?
Dr. Kahl's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.
Show 10 more questionsShow fewer questions
How many Medicare patients does Dr. Brad Steven Kahl see?
CMS counts 456 Medicare patients who saw Dr. Kahl in 2024, with an average age of 73.
Is Dr. Brad Steven Kahl board certified?
Yes. Dr. Kahl is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Brad Steven Kahl bill to Medicare?
In 2024, Dr. Kahl's most billed Medicare services were injected or infused drug (J1561), injected or infused drug (J1100) and hospital inpatient care (99232).
Where did Dr. Brad Steven Kahl go to medical school?
Dr. Kahl graduated from Tufts University School Of Medicine in 1994.
What drugs does Dr. Brad Steven Kahl prescribe most?
In 2024 Medicare Part D data, Dr. Kahl's most prescribed drugs by claims were Brukinsa, Acyclovir and Prochlorperazine Maleate.
Has Dr. Brad Steven Kahl received payments from drug or device companies?
CMS Open Payments shows $420,019 in general payments to Dr. Kahl from 27 companies from 2016 to 2025. The largest total came from Genentech, Inc.
How long has Dr. Brad Steven Kahl been practicing?
Dr. Kahl graduated from medical school in 1994, 32 years ago.
Does Dr. Brad Steven Kahl do research?
Dmand AI links 250 publications to Dr. Kahl, published from 2006 to 2025. Dr. Kahl has worked on 18 clinical trials.
Who does Dr. Brad Steven Kahl publish with?
Dr. Kahl's most frequent co-authors are Nancy Lee Bartlett, MD (35 shared papers), John P. Leonard, MD (35 shared papers) and Ranjana Advani, MD (23 shared papers).
What insurance does Dr. Brad Steven Kahl accept?
Dr. Kahl is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.
Selling to medical oncology practices?
See medical oncologists in Missouri by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card